螺杆菌属与原发性肝癌关系的研究进展

doi:10.11904/j.issn.1002-3070.2018.03.017

实用肿瘤学杂志 ›› 2018, Vol. 32 ›› Issue (3): 271-274.doi: 10.11904/j.issn.1002-3070.2018.03.017

螺杆菌属与原发性肝癌关系的研究进展

石小康^1,2(综述), 丁佑铭^1,2(审校)

1.武汉大学人民医院肝胆腔镜外科(武汉 430060);
2.消化系统疾病湖北省重点实验室

收稿日期:2017-03-19 出版日期:2018-07-10 发布日期:2018-07-10
通讯作者: 丁佑铭,E-mail:dingym@whu.edu.cn
作者简介:石小康,男,(1994-),硕士研究生,从事肝癌临床与基础的研究

Research progress on the relationship between helicobacter and primary hepatocellular carcinoma

SHI Xiaokang^1,2,DING,Youming^1,2

1.Department of Hepatobiliary and Laparoscopic Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,China;
2.Hubei Key Laboratory of Digestive System Disease

Received:2017-03-19 Online:2018-07-10 Published:2018-07-10

摘要/Abstract

摘要： 螺杆菌属(Helicobacter)是一类与人类多种疾病相关的菌属。研究发现,螺杆菌感染与原发性肝癌的发生发展密切相关,其不仅可以通过炎症刺激、细胞周期调控等促进肝癌的形成,还可通过TLR4/MyD88信号通路等增强肝癌细胞的侵袭能力。本文主要就螺杆菌感染与原发性肝癌的发生及发展关系予以综述。

关键词: 幽门螺杆菌, 肝螺杆菌, 肝癌

Abstract: Helicobacter is a class of genus associated with many human diseases.The existing studies have found that helicobacter infection is closely related to the occurrence and development of primary liver cancer.Not only can it promote the formation of liver cancer through inflammatory stimuli and regulation of cell cycle,but it can also enhance the invasive ability of liver cancer cells through TLR4 / MyD88 signaling pathway.This article summarizes the relationship between helicobacter infection and the occurrence and development of primary liver cancer.

Key words: Helicobacter pylori, Helicobacter hepaticus, Hepatocellular carcinoma

中图分类号:

R735.7

石小康(综述), 丁佑铭(审校). 螺杆菌属与原发性肝癌关系的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 271-274.

SHI Xiaokang, DING, Youming. Research progress on the relationship between helicobacter and primary hepatocellular carcinoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 271-274.

参考文献

1 Torre LA,Siegel RL,Ward EM,et al.Global cancer incidence and mortality rates and trends——an Update[J].Cancer Epidemiol Biomarkers Prev,2016,25(1):16-27.
2 OzakyolA.Globalepidemiology of hepatocellular carcinoma(HCC)epidemiology[J].J Gastrointest Cancer,2017,48(3):238-240.
3 Rich NE,Yopp AC,Singal AG.et al.Medical management of hepatocellular carcinoma[J].J Oncol Pract,2017,13(6):356-364.
4 Huang J,Zagai U,Hallmans G,et al.Helicobacter pylori infection,chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition(EPIC)cohort:a nested case-control study[J].Int J Cancer,2017,140(8):1727-1735.
5 Venerito M,Vasapolli R,Rokkas T,et al.Helicobacter pylori,gastric cancer and other gastrointestinal malignancies[J].Helicobacter,2017,22(1):e12413.
6 Marshall BJ,Warren JR.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration[J].Lancet,1984,323(8390):1311-1315.
7 Fox JG,Dewhirst FE,Tully JG,et al.Helicobacter hepaticus sp.nov.,a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice[J].Clin Microbiol,1994,32(5):1238-1245.
8 Falsafi T,ahboubi M.Helicobacter hepaticus,a new pathogenic species of the Helicobacter genus:Similarities and differences with H.pylori[J].Ira J Microbiol,2013,5(3):185-194.
9 Battles JK,Williamson JC,Pike KM,et al.Diagnostic assay for Helicobacter hepaticus based on nucleotide sequence of its 16S rRNA gene[J].J Clin Microbiol,1995,33(5):1344-1347.
10 Pellicano R,Ménard A,Rizzetto M,et al.Helicobacter,species and liver diseases:association or causation?[J].Lancet Infect Dis,2008,8(4):254-260.
11 Pirouz T,Zounubi L,Keivani H,et al.Detection of Helicobacterpylori,in paraffin-embedded specimens from patients with chronic liver diseases using the amplification method[J].Dig Dis Sci,2009,54(7):1456-1459.
12 Yang J,Ji S,Zhang Y,et al.Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue[J].Singapore Me J,2013,54(8):451-457.
13 JG Fox,Y Feng,Theve EJ,et al.Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens[J].Gut,2011,1(1):88-97.
14 García A,Feng Y,Parry NM,et al.Helicobacter pylori infection does not promote hepatocellular cancer in a transgenic mouse model of hepatitis C virus pathogenesis[J].Gut,2013,4(6):577-590.
15 Armstrong H,Bording-Jorgensen M,Dijk S,et al.The complex interplay between chronic inflammation,the microbiome,and cancer:understanding disease progression and what we can do to prevent it[J].Cancers,2018,10(3):83.
16 Kleine M,Worbs T,Schrem H,et al.Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes[J].PLoS One,2014,9(6):e99713.
17 Ben-Neriah Y,Karin M.Inflammation meets cancer,with NF-B as the matchmaker[J].Nature Immunology,2011,12(8):715-723.
18 Fu XT,Dai Z,Song K,et al.Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway[J].Int J Oncol,2015,46(2):587-596.
19 Snider JL,Allison C,Bellaire BH,et al.The beta1 integrin activates JNK independent of Cag A,and JNK activation is required for Helicobacter pylori CagA+/-induced motility of gastric cancer cells[J].J Biol Chem,2008,283(20):13952-13963.
20 Wang J,Wang X,Tang N,et al.Impact of Helicobacter pylori on the growth of hepatic orthotopic graft tumors in mice[J].Int J Oncol,2015,47(4):1416-1428.
21 Wang,SC.PCNA:a silent housekeeper or a potential therapeutic target?[J].Trends Pharmacol Sci,2014,35(4):178-186.
22 王若谷,陈国林.Bcl-2在肝癌和胰腺癌中的表达及意义[J].实用肿瘤学杂志,2007,21(2):161-163.
23 ItoK,Yamaoka YH,El-Zimaity H,et al.Adherence,internalization,and persistence of helicobacter pylori in hepatocytes[J].Dig Dis Sci,2008,53(9):2541-2549.
24 Ru Y,Chen XJ,Zhao ZW,et al.CyclinD1 and p57kip2 as biomarkers in differentiation,metastasis and prognosis of gastric cardia adenocarcinoma[J].Oncotarget,2017,8(43):73860-73870.
25 张春忙,彭凡洲,邓慧敏,等.肝螺杆菌对肝癌细胞侵袭能力的影响及其可能分子机制[J].现代消化及介入诊疗,2015,20(3):206-211.
26 张福星,张思宇,苏国强,等.幽门螺杆菌感染与原发性肝癌侵袭转移的关系[J].临床肿瘤学杂志,2010,15(2):123-126.
27 Desgrosellier JS,Cheresh DA.Integrins in cancer:biological implications and therapeutic opportunities[J].Nat Rev Cancer,2010,10(1):9-22.
28 Mitchell H,Katelaris P.Epidemiology,clinical impacts and current clinical management of Helicobacter pylori infection[J].Med J Aust,2016,204(10):376-380.

[1]	孙力超,杨婧,孙立新,张媛,杨治华,冉宇靓. 采用肝癌球体细胞筛选鉴定识别肝癌干细胞的单抗[J]. 实用肿瘤学杂志, 2019, 33(3): 193-199.
[2]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[3]	徐兵, 黄素钦, 吴林岚, 魏建威, 杨晓梅, 赵芝萍, 陈怡, 蒋晓织. 异体淋巴细胞和自体淋巴细胞序贯局部注射对小鼠肝癌移植瘤的治疗作用[J]. 实用肿瘤学杂志, 2018, 32(6): 493-497.
[4]	贺伟, 母齐鸣, 王刚, 万波, 廖波, 杨娟. TACC3和p53蛋白在原发性肝癌组织中的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 420-425.
[5]	文娟娟, 瞿兵, 刘超. 肝癌组织中抗凝血酶Ⅲ基因表达的临床意义[J]. 实用肿瘤学杂志, 2018, 32(2): 117-121.
[6]	王睿,余陈欢,方杰. miR-409-5p对肝癌细胞系HepG2增殖及迁移的影响[J]. 实用肿瘤学杂志, 2017, 31(4): 305-309.
[7]	周春芳，赵珊珊，孙泽群，吴军，查火龙，袁雅红. 酸性环境诱导肝癌HepG2细胞EMT[J]. 实用肿瘤学杂志, 2017, 31(3): 199-204.
[8]	张丽霞，潘双花，何英平. 原发性肝癌患者心电图与转氨酶和电解质的相关性研究[J]. 实用肿瘤学杂志, 2016, 30(6): 523-526.
[9]	杨晓文, 于爱清, 杨毅. Nanog调控细胞周期相关蛋白影响HepG2细胞增殖能力[J]. 实用肿瘤学杂志, 2016, 30(5): 425-429.
[10]	赵相轩, 温锋, 毛晓楠综述, 卢再鸣审校. 细胞凋亡在原发性肝癌治疗中的作用研究进展[J]. 实用肿瘤学杂志, 2016, 30(5): 448-452.
[11]	余庆, 张文美, 孙迎迎, 龚媛媛, 李东升, 王小莉. TRIM5α对肝癌细胞增殖和凋亡的影响[J]. 实用肿瘤学杂志, 2016, 30(2): 103-108.
[12]	康振国, 纪卫政, 顾俊鹏, 朱帝文, 张海潇, 任伟新. 肝癌射频消融术后联合替吉奥节拍化疗的疗效评价[J]. 实用肿瘤学杂志, 2016, 30(1): 17-22.
[13]	李凯, 杨光, 沈海洋, 刘家. 巨块型肝癌患者首次TACE后发热的临床意义及影响因素[J]. 实用肿瘤学杂志, 2015, 29(6): 528-532.
[14]	尹立楠, 刘岩. 微波消融治疗肝癌187例的临床疗效评价研究[J]. 实用肿瘤学杂志, 2015, 29(5): 395-399.
[15]	曲文书,华海清. 原发性肝癌骨转移55例预后分析[J]. 实用肿瘤学杂志, 2015, 29(4): 327-332.

螺杆菌属与原发性肝癌关系的研究进展

Research progress on the relationship between helicobacter and primary hepatocellular carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价